FFA
KRYS icon

Farther Finance Advisors’s Krystal Biotech KRYS Stock Holding History

Farther Finance Advisors’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$35.1K Buy
105
+22
+27% +$7.62K ﹤0.01% 3707
2026
Q2 		$30.9K Buy
83
+28
+51% +$8.37K ﹤0.01% 3637
2026
Q1 		$14.2K Buy
55
+16
+41% +$4.26K ﹤0.01% 3890
2025
Q4 		$9.62K Buy
39
+6
+18% +$1.26K ﹤0.01% 3948
2025
Q3 		$5.83K Buy
33
+9
+38% +$1.35K ﹤0.01% 3693
2025
Q2 		$3.3K Buy
24
+1
+4% +$147 ﹤0.01% 3525
2025
Q1 		$4.01K Hold
23
– – ﹤0.01% 3153
2024
Q4 		$3.6K Hold
23
– – ﹤0.01% 2794
2024
Q3 		$4.19K Buy
23
+4
+21% +$771 ﹤0.01% 2716
2024
Q2 		$3.46K Hold
19
– – ﹤0.01% 2557
2024
Q1 		$3.35K Hold
19
– – ﹤0.01% 2261
2023
Q4 		$2.36K Buy
19
+16
+533% +$1.77K ﹤0.01% 2365
2023
Q3 		$348 Hold
3
– – ﹤0.01% 2350
2023
Q2 		$352 Buy
+3
New +$306 ﹤0.01% 2246

Other funds holding KRYS

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
NWMP
Noble Wealth Management PBC Greenwood Village, Colorado $223M AUM 7.64% 1-Year Est. Return

Farther Finance Advisors's KRYS Position: Q3 2026 in Review

Farther Finance Advisors increased its Krystal Biotech (KRYS) stake by 27% in Q3 2026, buying an estimated $7.62K and bringing the position to 105 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3707.

Farther Finance Advisors first reported a position in KRYS in Q2 2023 and has held it in 14 quarters since. 11 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Farther Finance Advisors held 105 shares of Krystal Biotech worth $35.1K as of Q3 2026.
  • Farther Finance Advisors bought 22 Krystal Biotech shares in Q3 2026, an estimated $7.62K.
  • Krystal Biotech made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3707 holding.
  • Farther Finance Advisors first reported a position in Krystal Biotech in Q2 2023 and has held it in 14 quarters since.
  • 11 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.